In summary, our data on endometrial carcinoma show that overexpression of AURKA is strongly associated with tumor grade and histological type, and that there is a correlation between expression of AURKA and sensitivity to paclitaxel. The gene discussed is AURKA; the disease is endometrial carcinoma.